Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 133.30%86.22M | 55.99%61.01M | 22.26%44M | 16.85%164.56M | 81.24%54.33M | 11.52%36.95M | 1.79%39.11M | -8.82%35.99M | -9.76%140.83M | -16.49%29.98M |
| Cost of revenue | 158.80%80.57M | 70.53%55.03M | 26.61%37.88M | 16.81%138.86M | 88.83%47.44M | 8.01%31.13M | 0.35%32.27M | -10.76%29.92M | -13.56%118.87M | -24.36%25.12M |
| Gross profit | -3.08%5.64M | -12.63%5.98M | 0.79%6.11M | 17.06%25.7M | 41.96%6.89M | 34.96%5.82M | 9.23%6.84M | 2.12%6.07M | 18.43%21.95M | 80.89%4.86M |
| Operating expense | -60.13%2.98M | 37.31%4.97M | 25.12%3.42M | -4.59%16.72M | -97.33%107K | 82.48%7.47M | 13.11%3.62M | -35.25%2.73M | -46.24%17.53M | -78.45%4.01M |
| Selling and administrative expenses | -52.89%3.72M | 27.85%5.47M | 3.31%4.12M | -0.08%18.45M | -49.27%2.55M | 93.13%7.91M | -10.25%4.28M | -21.52%3.99M | -5.79%18.46M | -10.21%5.02M |
| -Selling and marketing expense | 173.58%528K | 21.65%309K | 6.57%227K | 34.11%1.43M | 125.88%768K | -26.62%193K | 4.96%254K | -23.93%213K | -22.11%1.06M | 18.13%340K |
| -General and administrative expense | -58.56%3.2M | 28.24%5.16M | 3.13%3.89M | -2.17%17.02M | -61.99%1.78M | 101.36%7.71M | -11.07%4.03M | -21.38%3.78M | -4.57%17.4M | -11.75%4.68M |
| Other operating expenses | ---- | ---- | ---- | -38.41%298.83K | ---- | ---- | ---- | ---- | -97.31%485.18K | ---- |
| Total other operating income | 71.10%746K | -23.64%507K | -44.04%704K | 42.65%2.02M | 140.97%2.44M | --436K | -57.76%664K | 45.43%1.26M | -71.66%1.42M | --1.01M |
| Operating profit | 261.65%2.66M | -68.66%1.01M | -19.14%2.7M | 102.93%8.97M | 702.96%6.79M | -849.09%-1.65M | 5.19%3.22M | 93.72%3.33M | 131.41%4.42M | 105.31%845K |
| Net non-operating interest income (expenses) | 7.87%-480K | -2.42%-508K | -22.54%-560K | 404.24%590.19K | -38.19%-655K | 8.60%-521K | 9.65%-496K | 15.68%-457K | 111.51%117.05K | -620.74%-474K |
| Non-operating interest income | ---- | ---- | ---- | 18.04%2.67M | ---- | ---- | ---- | ---- | 268.16%2.26M | ---- |
| Non-operating interest expense | -7.87%480K | 2.42%508K | 22.54%560K | -3.07%2.08M | 38.19%655K | -8.60%521K | -9.65%496K | -15.68%457K | 31.33%2.14M | -9.26%474K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -8.02%436K | |||||||||
| Income before tax | 200.69%2.18M | -81.59%502K | -25.76%2.14M | 110.70%9.56M | 1,552.29%6.13M | -1,849.19%-2.17M | 8.43%2.73M | 144.02%2.88M | 130.07%4.54M | 101.76%371K |
| Income tax | -25.00%825K | -48.31%107K | 275.00%1.07M | 31.63%3.79M | 11.15%2.36M | 947.62%1.1M | 132.58%207K | 125.40%284K | -18.15%2.88M | -15.83%2.13M |
| Net income | 141.57%1.36M | -84.33%395K | -58.70%1.07M | 247.58%5.78M | 314.82%3.77M | -17,305.26%-3.27M | 3.87%2.52M | 146.25%2.59M | 108.93%1.66M | 92.58%-1.75M |
| Net income continuous operations | 141.57%1.36M | -84.33%395K | -58.70%1.07M | 247.58%5.78M | 314.82%3.77M | -17,305.26%-3.27M | 3.87%2.52M | 146.25%2.59M | 108.93%1.66M | 92.58%-1.75M |
| Noncontrolling interests | 240.17%1.31M | 278.71%663K | -517.24%-537K | 21.39%-349.46K | 199.48%955K | -2,500.00%-936K | -253.94%-371K | -135.08%-87K | 73.74%-444.57K | -546.45%-960K |
| Net income attributable to the company | 102.01%47K | -109.27%-268K | -40.00%1.61M | 190.81%6.12M | 454.28%2.81M | -4,341.82%-2.33M | 32.31%2.89M | 232.92%2.68M | 112.45%2.11M | 96.67%-794K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 102.01%47K | -109.27%-268K | -40.00%1.61M | 190.81%6.12M | 454.28%2.81M | -4,341.82%-2.33M | 32.31%2.89M | 232.92%2.68M | 112.45%2.11M | 96.67%-794K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0 | -110.00%-0.0001 | -44.44%0.0005 | 185.71%0.002 | 400.00%0.0009 | -4,544.44%-0.0008 | 42.86%0.001 | 200.00%0.0009 | 112.28%0.0007 | 96.25%-0.0003 |
| Diluted earnings per share | 0 | -110.00%-0.0001 | -44.44%0.0005 | 185.71%0.002 | 400.00%0.0009 | -4,544.44%-0.0008 | 42.86%0.001 | 200.00%0.0009 | 112.28%0.0007 | 96.25%-0.0003 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.